News search

Dr. Carla Rothlin is Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at the Yale School of Medicine, and co-leader of the Cancer Immunology Programme at Yale Cancer Centre. She studied biochemistry and pharmacology at the University of Buenos Aires, where she also undertook her postgraduate research under the direction of Dr. Ana Belén Elgoyhen, focussing on nicotinic receptors expressed in the inner ear. Later, she completed her doctorate and moved to San Diego to join Dr. Greg Lemke’s laboratory at the Salk Institute for Biological Studies. In 2009, Dr. Rothlin was named Assistant Professor in Immunobiology at Yale Medical School

The Spanish National Centre for Cardiovascular Research (CNIC) researcher Dr Ana Paredes has won the International Birnstiel Award 2023

The results of the SPHERE-HF study are published in the European Journal of Heart Failure. SPHERE-HF is a multicenter academic clinical trial led by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Hospital Clínic de Barcelona

Akiko Iwasaki, with some other scientists, helped create a plan to stop Covid-19. She has also spoken out about the barrier’s women face in the field of biology

The research team led by project leader Dr Silvia Priori is confident that the discovery of new therapies will reduce the mortality linked to this disease and could also reduce arrhythmias in heart failure patients

This project represents a major development in the need to implement early cardiovascular intervention strategies that are capable of reducing the incidence of AD at the advanced ages in Alzheimer's disease